US Archives - Page 89 of 99 - European Medical Journal

Nebulization and Viral Spread: Knowns and Unknowns in the Healthcare Setting

An infographic on administering aerosol treatments by nebulization, aiming to educate physicians to build upon knowledge of overall safety

Before, During, and after COVID: What Changed in the ICU?

The SARS-CoV-2 2019 pandemic has resulted in a rise in the need for intensive care units (ICU) and mechanical ventilation due to…

Review of the American Thoracic Society (ATS) International Congress 2024

This year, the 2024 International Conference of the American Thoracic Society (ATS) took place in San Diego, California, USA…

The latest edition of AMJ Respiratory is out now!

This new issue of our American Respiratory journal is packed with cutting-edge insights and updates from the ATS International congress…

Muscle Mass Improvement after Lung Volume Reduction Interventions in COPD

Lung volume reduction is performed in a highly select population of patients with chronic obstructive pulmonary disease (COPD)…

Advancements in Lung Cancer Screening, Treatment, and Survivorship

Matthew Triplette, Fred Hutchinson Cancer Center and University of Washington, Seattle, USA, delivered an insightful talk…

Electronic Order Set in Latent Tuberculosis Infection Screening for Immunosuppression

Before 2021 in Calgary, Canada, hospitalized inpatient latent tuberculosis infection (LTBI) screening, with a QuantiFERON assay (QFT)…

Sarcoid Versus Tuberculosis, or Both?

Sarcoidosis and tuberculosis (TB) share similar clinical, histological, and radiographical characteristics, and can be difficult to…

Epidemiological Trends in Lung and Bronchus Cancer In Michigan Over 21 Years

As a leading cause of death in the USA, lung and bronchus cancer has claimed the lives of many individuals across the nation…

Genitourinary Tuberculosis Resulting in Hydronephrosis

Genitourinary tuberculosis (GUTB) results from hematogenous spread of chronic latent pulmonary tuberculosis of 5–40 years…